Uncertain recovery at this stage
19/02/26 -"The reduction of the target price is derived from the downward revision of our EPS expectations and DCF valuation (see the respective comments). The start of 2026 does not indicate a meaningful ..."
Pages
49
Language
English
Published on
19/02/26
You may also be interested by these reports :
19/02/26
The reduction of the target price is derived from the downward revision of our EPS expectations and DCF valuation (see the respective comments). The ...
17/02/26
DKSH’s FY25 result has been well received, with the share price rising ~7% on strong core EBIT growth. Sales and EBIT growth at CER exceeded ...
14/02/26
Terminix turnaround on track
11/02/26
SGS’ 2025 results met expectations on sales, including organic growth, and were ahead on profits. The beat on profits resulted from the successful ...